Don Smith

5.4k total citations
95 papers, 3.0k citations indexed

About

Don Smith is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Don Smith has authored 95 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Infectious Diseases, 43 papers in Virology and 32 papers in Epidemiology. Recurrent topics in Don Smith's work include HIV/AIDS Research and Interventions (45 papers), HIV Research and Treatment (43 papers) and HIV/AIDS drug development and treatment (32 papers). Don Smith is often cited by papers focused on HIV/AIDS Research and Interventions (45 papers), HIV Research and Treatment (43 papers) and HIV/AIDS drug development and treatment (32 papers). Don Smith collaborates with scholars based in Australia, United States and United Kingdom. Don Smith's co-authors include David A. Cooper, John Zaunders, Anthony D. Kelleher, Gilbert R. Kaufmann, Andrew Carr, Brian Gazzard, Pat Grey, Mark Bloch, Sean Emery and John Kaldor and has published in prestigious journals such as The Lancet, Blood and The Journal of Immunology.

In The Last Decade

Don Smith

91 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Don Smith Australia 28 1.5k 1.4k 865 815 649 95 3.0k
Karam Mounzer United States 30 1.4k 0.9× 1.4k 1.0× 974 1.1× 939 1.2× 471 0.7× 117 3.0k
Kenneth Rich United States 32 1.9k 1.3× 1.2k 0.9× 869 1.0× 414 0.5× 881 1.4× 80 3.3k
Nesli Basgoz United States 32 1.6k 1.1× 1.9k 1.4× 772 0.9× 949 1.2× 1.6k 2.5× 53 4.2k
Allan R. Tenorio United States 22 1.0k 0.7× 1.1k 0.8× 424 0.5× 647 0.8× 493 0.8× 55 2.4k
Andri Rauch Switzerland 34 1.7k 1.2× 1.0k 0.7× 1.9k 2.2× 410 0.5× 479 0.7× 145 3.8k
Matthias Stoll Germany 29 1.3k 0.9× 930 0.7× 1.1k 1.3× 271 0.3× 810 1.2× 104 3.2k
S. A. Danner Netherlands 21 1.4k 0.9× 1.7k 1.2× 636 0.7× 551 0.7× 352 0.5× 46 2.6k
Homayoon Farzadegan United States 28 2.9k 2.0× 2.5k 1.8× 1.7k 2.0× 701 0.9× 542 0.8× 77 4.9k
Cecilia M. Shikuma United States 35 2.3k 1.6× 2.0k 1.5× 959 1.1× 366 0.4× 1.8k 2.7× 156 4.2k
Ivano Mezzaroma Italy 27 884 0.6× 929 0.7× 580 0.7× 646 0.8× 255 0.4× 111 2.1k

Countries citing papers authored by Don Smith

Since Specialization
Citations

This map shows the geographic impact of Don Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Don Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Don Smith more than expected).

Fields of papers citing papers by Don Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Don Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Don Smith. The network helps show where Don Smith may publish in the future.

Co-authorship network of co-authors of Don Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Don Smith. A scholar is included among the top collaborators of Don Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Don Smith. Don Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Smith, Don, et al.. (2024). “How well do we know our patients?”: Further validation of a complexity rating scale for HIV. International Journal of STD & AIDS. 35(14). 1112–1119.
2.
Batterham, Rachel L., Núria Espinosa, Christine Katlama, et al.. (2023). Cardiometabolic Parameters 3 Years After Switch to Dolutegravir/Lamivudine vs Maintenance of Tenofovir Alafenamide–Based Regimens. Open Forum Infectious Diseases. 10(7). ofad359–ofad359. 6 indexed citations
3.
4.
Chan, Derek, Virginia Furner, Don Smith, et al.. (2018). Non-AIDS complexity amongst patients living with HIV in Sydney: risk factors and health outcomes. AIDS Research and Therapy. 15(1). 6–6. 7 indexed citations
5.
Siefried, Krista J., Limin Mao, Lucette A. Cysique, et al.. (2017). Concomitant medication polypharmacy, interactions and imperfect adherence are common in Australian adults on suppressive antiretroviral therapy. AIDS. 32(1). 35–48. 61 indexed citations
6.
Arnott, Alicia, Darren Jardine, Kim Wilson, et al.. (2010). High Viral Fitness during Acute HIV-1 Infection. PLoS ONE. 5(9). e12631–e12631. 18 indexed citations
7.
8.
Chan, Derek, et al.. (2008). Correlates of Unprotected Anal Intercourse in HIV Positive Men Attending an HIV/AIDS Clinic in Sydney§. Current HIV Research. 6(6). 579–584. 6 indexed citations
9.
Bloch, Mark, Don Smith, John Kaldor, et al.. (2006). The Role of Hydroxyurea in Enhancing the Virologic Control Achieved Through Structured Treatment Interruption in Primary HIV Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes. 42(2). 192–202. 18 indexed citations
10.
Martin, Allison, Don Smith, Andrew Carr, et al.. (2004). Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir. AIDS. 18(7). 1029–1036. 240 indexed citations
11.
Smith, Don, Gilbert R. Kaufmann, James O. Kahn, et al.. (2003). Greater Reversal of CD4 + Cell Abnormalities and Viral Load Reduction after Initiation of Antiretroviral Therapy with Zidovudine, Lamivudine, and Nelfinavir before Complete HIV Type 1 Seroconversion. AIDS Research and Human Retroviruses. 19(3). 189–199. 11 indexed citations
12.
Lewin, Sharon R., Ruy M. Ribeiro, Gilbert R. Kaufmann, et al.. (2002). Dynamics of T Cells and TCR Excision Circles Differ After Treatment of Acute and Chronic HIV Infection. The Journal of Immunology. 169(8). 4657–4666. 42 indexed citations
13.
Appay, Victor, John Zaunders, Laura Papagno, et al.. (2002). Characterization of CD4+ CTLs Ex Vivo. The Journal of Immunology. 168(11). 5954–5958. 435 indexed citations
14.
Kaufmann, Gilbert R., John Zaunders, John M. Murray, et al.. (2001). Relative Significance of Different Pathways of Immune Reconstitution in HIV Type 1 Infection as Estimated by Mathematical Modeling. AIDS Research and Human Retroviruses. 17(2). 147–159. 20 indexed citations
15.
Smith, Don, et al.. (2001). Baseline Antiretroviral Drug Susceptibility Influences Treatment Response in Patients Receiving Saquinavir-Enhancing Therapy. HIV Clinical Trials. 2(6). 445–452. 9 indexed citations
16.
Bloch, Mark, Andrew Carr, E Vasak, Philip Cunningham, & Don Smith. (1999). The use of human immunodeficiency virus postexposure prophylaxis after successful artificial insemination. American Journal of Obstetrics and Gynecology. 181(3). 760–761. 11 indexed citations
17.
Kell, P D, et al.. (1991). A maternal death caused by AIDS. Case report. BJOG An International Journal of Obstetrics & Gynaecology. 98(7). 725–727. 7 indexed citations
18.
Smith, Don, et al.. (1991). Itraconazole versus ketaconazole in the treatment of oral and oesophageal candidosis in patients infected with HIV. AIDS. 5(11). 1367–1372. 51 indexed citations
19.
Hayashi, Ken, et al.. (1991). Pathogenesis of corneal epithelial defects: Role of plasminogen activator. Current Eye Research. 10(5). 381–398. 27 indexed citations
20.
Smith, Don, et al.. (1988). SEVERE EXERCISE HYPOXAEMIA WITH NORMAL OR NEAR NORMAL X-RAYS: A FEATURE OF PNEUMOCYSTIS CARINII INFECTION. The Lancet. 332(8619). 1049–1051. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karam Mounzer Breakdown of academic impact, for papers by Kenneth Rich Breakdown of academic impact, for papers by Nesli Basgoz Breakdown of academic impact, for papers by Allan R. Tenorio Breakdown of academic impact, for papers by Andri Rauch Breakdown of academic impact, for papers by Matthias Stoll Breakdown of academic impact, for papers by S. A. Danner Breakdown of academic impact, for papers by Homayoon Farzadegan Breakdown of academic impact, for papers by Cecilia M. Shikuma Breakdown of academic impact, for papers by Ivano Mezzaroma
Rankless by CCL
2026